Analyst downgrades: TMA, KERX, ARO and WMT
Posted Mar 10th 2008 11:33AM by Eric Buscemi
Filed under: Analyst Reports, Analyst Upgrades and Downgrades, Wal-Mart (WMT)
.gif)
MOST NOTEWORTHY: Thornburg Mortgage, Keryx Biopharma and Aeropostale were today's noteworthy downgrades:
- Jefferies downgraded shares of Thornburg Mortgage (NYSE: TMA) to Underperform from Hold after the company said it is unable to meet margin calls despite asset sales and will restate 2007 earnings.
- Keryx Biopharma (NASDAQ: KERX) was downgraded to Neutral from Buy at Merrill, to Neutral from Overweight at JP Morgan, to Underperform from Market Perform at Rodman & Renshaw, to Hold from Buy at Jefferies and to Underperform from Outperform at Bear Stearns after the company announced the Sulonex SUN-MICRO Phase 3 trial failed to meet the primary endpoint.
- Citigroup lowered Aeropostale (NYSE: ARO) to Sell from Hold as they believe inventory levels are building and that there is downside risk to Q1 estimates.
OTHER DOWNGRADES:
Tags: aeropostale, analyst, aro, downgrade, j2 global, J2Global, jcom, kerx, keryx, lincare, lncr, thornburg, tma, wal-mart, wmt
Walmart's New Health Food Push: Is It Too Hard to Swallow?
Bonds Are a 'Safe' Investment: A Big Lie Gets Even Bigger
Goldman Earnings Sink After Buffett Dividend
Johnson & Johnson's Income Falls 23%
Burberry Shares Leap on Sales Update
